Kazia Therapeutics Limited
KZIA
$13.16
-$0.67-4.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.39% | 23.01% | 23.76% | -14.84% | -79.86% |
| Total Depreciation and Amortization | -100.03% | -75.33% | -49.64% | -24.77% | -0.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.16% | 64.25% | 73.58% | 329.53% | 516.38% |
| Change in Net Operating Assets | -131.39% | -130.24% | -129.42% | -59.27% | 193.72% |
| Cash from Operations | -21.17% | -27.37% | -37.75% | -11.35% | 8.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.04% | -100.08% |
| Total Debt Repaid | -- | -- | -- | 100.11% | 100.22% |
| Issuance of Common Stock | 502.65% | 354.51% | 109.56% | 23.06% | -19.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,878.33% | 3,346.55% | 1,029.26% | 520.87% | 255.54% |
| Cash from Financing | 635.63% | 465.02% | 165.42% | 49.45% | -8.45% |
| Foreign Exchange rate Adjustments | -488.54% | -468.06% | -192.77% | 6,888.89% | 1,473.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,495.69% | 1,797.13% | 174.10% | 148.90% | 37.79% |